XRAY NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Dentsply Sirona Inc · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data Download investor PDF
Latest close 12.93 USD
-8.0% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 9.0% above the Trend Line and sits at 54.6% of its 52-week range. The latest completed week returned -8.0%, after a 17.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 41/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: earnings are due in 7d.

Setup score 47 out of 100
Latest Close 12.93 USD 24 Jul 2026
1W Return -8.0% latest completed week
4W Return 17.4% short-term follow-through
12W Return 9.5% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -8.0% Latest completed week; four-week move 17.4%. Indicator stack 0/82 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 41/100 conviction; expected move 13.3%. News sentiment 54/100 53 relevant articles in the latest sentiment read. Event risk 7d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 9.0% above the Trend Line and sits at 54.6% of its 52-week range. The latest completed week returned -8.0%, after a 17.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2112-week average 0.08

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.21Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 17.4% over four weeks, 9.5% over 12 weeks, and -17.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-8.0%
4W17.4%
12W9.5%
26W1.6%
52W-17.2%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.84Latest activity-pressure read.
Pressure change212.7%Four-week change in activity pressure.
Leadership-2.38Latest relative-leadership reading.
RS change89.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength42/100Blend of value, momentum, and quality. Underlying universe rank 59; rank 1 is best.
Value73/100Relative valuation strength. Underlying universe rank 28; rank 1 is best.
Quality22/100Profitability and accounting quality. Underlying universe rank 79; rank 1 is best.
Momentum15/100Medium-term price momentum. Underlying universe rank 86; rank 1 is best.
Growth24/100Revenue and earnings growth. Underlying universe rank 77; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.7x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
48.9%
Gross profit retained from each unit of revenue.
Operating margin
-13.0%
Operating profit retained from revenue.
Free-cash-flow margin
11.7%
Free cash flow generated from revenue.
Return on invested capital
-10.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-1.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-28.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.5%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
2.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-16.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

XRAY shows bullish options pressure with a 41/100 conviction score, put-call volume ratio of 0.23, expected move of 13.3%, and Sharemaestro trend signal inactive.

Conviction41/100
Expected move13.3%
Put/call volume0.23
Pressure68
Speculation5
Volatility88
Trend agreement8
Open options detail
Insider activity18 / 2

18 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 53 relevant articles.

15 positive · 34 neutral · 4 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings7dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move13.3%Nearest-chain priced movement where available.
52-week drawdown-18.5%Distance below the 52-week high.
13-week volatility6.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+17.1%Week of 27 Feb.
Worst week-13.2%Week of 6 Mar.
Latest week-8.0%Week of 24 Jul.

Shape of recent returns

Strong gains8
Modest gains6
Flat weeks0
Modest losses3
Sharp losses9
Recent vol6.4%13-week weekly-return volatility.
Base vol6.8%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew5.5% / -5.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape39/100

Trend, activity pressure, participation, and risk combine to a 39/100 tape read.

 Indicator analysis19/100

Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 1/12.

Activity pressure 0.21; No reversal markers Factors37/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 56; Small Cap Core rank 31 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options44/100

XRAY shows bullish options pressure with a 41/100 conviction score, put-call volume ratio of 0.23, expected move of 13.3%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 13.3% Sentiment54/100

Weighted news tone is neutral across 53 relevant articles.

Dentsply Sirona to Host Second Quarter Conference Call on August 6th Insiders18 / 2

18 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings7d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202612.93 USD-8.0%11.86 USD19.95 USD0.84-2.3826.8MOff
17 Jul 202614.05 USD14.6%11.81 USD20.11 USD0.723.4828.7MOff
10 Jul 202612.26 USD5.2%11.71 USD20.26 USD0.16-14.0623.7MOff
3 Jul 202611.65 USD5.8%11.68 USD20.43 USD-0.37-17.7919.2MOff
26 Jun 202611.01 USD6.6%11.66 USD20.58 USD-0.75-22.6151.4MOff
19 Jun 202610.33 USD2.4%11.67 USD20.75 USD-0.98-31.5019.0MOff
12 Jun 202610.09 USD0.9%11.67 USD20.91 USD-0.90-32.2121.4MOff
5 Jun 202610.00 USD-4.5%11.68 USD21.08 USD-0.78-32.2024.2MOff
29 May 202610.47 USD2.5%11.72 USD21.24 USD-0.52-33.1232.7MOff
22 May 202610.21 USD1.4%11.78 USD21.40 USD-0.50-33.8331.6MOff
15 May 202610.07 USD-8.5%11.87 USD21.55 USD-0.46-34.8328.9MOff
8 May 202611.00 USD-6.9%11.95 USD21.73 USD-0.34-30.0836.3MOff
1 May 202611.81 USD-0.8%11.97 USD21.90 USD-0.41-21.8820.1MOff
24 Apr 202611.91 USD-4.8%12.01 USD22.06 USD-0.43-20.7014.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.